CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 105 filers reported holding CLOVIS ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $475,000 | +379.8% | 399,039 | +1827.2% | 0.06% | +293.8% |
| Q4 2020 | $99,000 | 0.0% | 20,706 | +32.9% | 0.02% | -36.0% |
| Q1 2020 | $99,000 | -51.2% | 15,576 | -20.0% | 0.02% | +4.2% |
| Q4 2019 | $203,000 | +89.7% | 19,482 | -28.3% | 0.02% | +71.4% |
| Q3 2019 | $107,000 | -91.3% | 27,178 | +94.1% | 0.01% | -70.2% |
| Q2 2015 | $1,230,000 | +162.8% | 14,000 | +121.9% | 0.05% | +147.4% |
| Q1 2015 | $468,000 | +37.6% | 6,309 | +11.9% | 0.02% | -29.6% |
| Q4 2013 | $340,000 | +11.8% | 5,637 | +12.7% | 0.03% | +12.5% |
| Q3 2013 | $304,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |